Moderna Interested in Germany Production, Sees Opportunity in BioNTech Closures, Says CEO - Regional Media News
10 Articles
10 Articles
The US pharmaceutical company Moderna wants to invest in Germany and shows interest in plants of the former competitor BioNTech. At the same time, Moderna demands better conditions for pharmaceutical companies.
Moderna interested in Germany production, sees opportunity in BioNTech ...
The US pharmaceutical company Moderna is considering the purchase of plants that the German company Biontech intends to close.
The planned closures of Biontech sites in Germany could play into the hands of the competitor Moderna: The US biotech company shows interest in plants. However, under conditions.
The head of the US biotech company, Stéphane Bancel, envisages investments in Germany. In view of all, he has plants and personnel of the competitor Biontech. On one condition.
The US pharmaceutical company Moderna is interested in plants in Germany that its competitor BioNTech plans to close. Moderna CEO Stéphane Bancel says he "really wants to invest," but sets one condition.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
